Author:
Hobohm Lukas,Konstantinides Stavros
Reference23 articles.
1. Agnelli G, Becattini C, Meyer G et al.: Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med 382(17) (2020) 1599–1607
2. Aujesky D, Roy PM, Verschuren F et al.: Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2 378(9785) (2011) 41–48
3. Bajaj A, Saleeb M, Rathor P et al.: Prognostic value of troponins in acute nonmassive pulmonary embolism: A meta-analysis. Heart Lung 44(4) (2015) 327–334
4. Barco S, Mahmoudpour SH, Planquette B, et al. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 40 (2019) 902–910
5. Barco S, Schmidtmann I, Ageno W, et al. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J 41 (2020) 509–518